Mast cell tumor epidemiology and demographics
|
Mast cell tumor Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Mast cell tumor epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Mast cell tumor epidemiology and demographics |
|
Risk calculators and risk factors for Mast cell tumor epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Epidemiology and Demographics
Systemic mastocytosis is a rare disease characterized by abnormal growth and accumulation of mast cells in various organ.[1] Mastocytosis is a rare disease and is considered to be an "orphan disease" affecting 200,000 or fewer people in the United States.
Incidence
There are no definite data regarding the exact incidence and prevalence of mast cell tumor among the US general population.[2]
Age
- Patients of all age groups may develop mast cell tumor.
- Cutaneous mastocytosis is more common in children and the disease manifest itself in the first year of life in over 80% of cases.[3]
- Second smaller peak of incidence is observed in adults in the third to fourth decade.[3]
Gender
There is no sex predilection to the mast cell tumor.
Race
There is no racial predilection to the mast cell tumor.
References
- ↑ Koenig, Martial; Morel, Jérôme; Reynaud, Jacqueline; Varvat, Cécile; Cathébras, Pascal (2008). "An unusual cause of spontaneous bleeding in the intensive care unit – mastocytosis: a case report". Cases Journal. 1 (1): 100. doi:10.1186/1757-1626-1-100. ISSN 1757-1626.
- ↑ Brockow K (2014). "Epidemiology, prognosis, and risk factors in mastocytosis". Immunol Allergy Clin North Am. 34 (2): 283–95. doi:10.1016/j.iac.2014.01.003. PMID 24745674.
- ↑ 3.0 3.1 Ferrante, Giuliana; Scavone, Valeria; Muscia, Maria; Adrignola, Emilia; Corsello, Giovanni; Passalacqua, Giovanni; La Grutta, Stefania (2015). "The care pathway for children with urticaria, angioedema, mastocytosis". World Allergy Organization Journal. 8 (1): 5. doi:10.1186/s40413-014-0052-x. ISSN 1939-4551.